Citation Impact

Citing Papers

Selective delivery of β cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8 + T cells in NOD mice
2008 StandoutNobel
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
2009 Standout
Transplant tolerance through costimulation blockade - are we there yet?
2007
PDL1 Is Required for Peripheral Transplantation Tolerance and Protection from Chronic Allograft Rejection
2007
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
2017 StandoutNature
Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
2010 Standout
Reinvigorating exhausted HIV-specific T cells via PD-1–PD-1 ligand blockade
2006
Cardiac-specific blockade of NF-κB in cardiac pathophysiology: differences between acute and chronic stimuli in vivo
2005
Monocyte recruitment during infection and inflammation
2011 Standout
Inflammatory links between obesity and metabolic disease
2011 Standout
Fatal Autoimmune Hepatitis Induced by Concurrent Loss of Naturally Arising Regulatory T Cells and PD-1-Mediated Signaling
2008 StandoutNobel
T cell exhaustion
2011 Standout
CD22 blockade restores homeostatic microglial phagocytosis in ageing brains
2019 StandoutNatureNobel
The PD-1–PD-L pathway in immunological tolerance
2006 StandoutNobel
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
Type I interferons in infectious disease
2015 Standout
Systematic comparison of CRISPR/Cas9 and RNAi screens for essential genes
2016
Atherosclerosis: current pathogenesis and therapeutic options
2011 Standout
TNF superfamily in inflammatory disease: translating basic insights
2011
CRISPR-Cas9 screens identify regulators of antibody–drug conjugate toxicity
2019 StandoutNobel
Type I Interferons Promote Fatal Immunopathology by Regulating Inflammatory Monocytes and Neutrophils during Candida Infections
2012
IKKβ inhibition attenuates myocardial injury and dysfunction following acute ischemia-reperfusion injury
2007
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
2017 Standout
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
The immune system in atherosclerosis
2011 Standout
The year in atherothrombosis
2004
Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities
2010 Standout
T-Cell Costimulatory Pathways in Allograft Rejection and Tolerance
2005
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Molecular mechanisms of T cell co-stimulation and co-inhibition
2013 Standout
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
2015 Standout
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
2011 StandoutNobel
Negative regulators of T‐cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections
2009 StandoutNobel
Cancer immunotherapy comes of age
2011 StandoutNature
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
2008 Standout
Predominant expression of B7-H1 and its immunoregulatory roles in oral squamous cell carcinoma
2005
Immunomodulatory therapy for severe influenza
2011
Protective and pathogenic functions of macrophage subsets
2011 Standout
Tissue-Specific Effects of the Nuclear Factor κB Subunit p50 on Myocardial Ischemia-Reperfusion Injury
2007
Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice
2007
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
Molecular and cellular insights into T cell exhaustion
2015 Standout
The acute respiratory distress syndrome
2012 Standout
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
2015 Standout
A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application
2013 StandoutNobel
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication
2011 StandoutNobel
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection
2007
Depot-specific differences in inflammatory mediators and a role for NK cells and IFN-γ in inflammation in human adipose tissue
2009
PD-L1 partially protects renal tubular epithelial cells from the attack of CD8+cytotoxic T cells
2007
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway
2008 StandoutNobel
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Follicular Helper CD4 T Cells (TFH)
2011 Standout
PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice
2011 StandoutNobel
Regulation of Macrophage Functions by PPAR-α, PPAR-γ, and LXRs in Mice and Men
2008
Cell intrinsic mechanisms of T‐cell inhibition and application to cancer therapy
2008 StandoutNobel
Differential Effects of B and T Lymphocyte Attenuator and Programmed Death-1 on Acceptance of Partially versus Fully MHC-Mismatched Cardiac Allografts
2005
Endothelial Programmed Death-1 Ligand 1 (PD-L1) Regulates CD8 + T-Cell–Mediated Injury in the Heart
2007
TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection
2009 Nobel
Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model
2012 StandoutNobel
Anti-Programmed Cell Death 1 Antibody Reduces CD4+PD-1+ T Cells and Relieves the Lupus-Like Nephritis of NZB/W F1 Mice
2010 StandoutNobel
Unexpected protective role for Toll-like receptor 3 in the arterial wall
2011
The Programmed Death-1 and Interleukin-10 Pathways Play a Down-Modulatory Role in LP-BM5 Retrovirus-Induced Murine Immunodeficiency Syndrome
2007 StandoutNobel
T-Cell Costimulation and Coinhibition in Atherosclerosis
2008
Targeted Deletion of Nuclear Factor κB p50 Enhances Cardiac Remodeling and Dysfunction Following Myocardial Infarction
2009
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
Role of the Programmed Death-1 Pathway in Regulation of Alloimmune Responses In Vivo
2005
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
2017 Standout
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
2016 Standout
Identification of Activators of ERK5 Transcriptional Activity by High-Throughput Screening and the Role of Endothelial ERK5 in Vasoprotective Effects Induced by Statins and Antimalarial Agents
2014
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
PD-1 and Its Ligands in Tolerance and Immunity
2008 Standout

Works of Go Haraguchi being referenced

PPARα and PPARγ activators suppress the monocyte-macrophage apoB-48 receptor
2003
Pioglitazone reduces systematic inflammation and improves mortality in apolipoprotein E knockout mice with sepsis
2008
Inhibition of NF-κB improves left ventricular remodeling and cardiac dysfunction after myocardial infarction
2006
Attenuation of experimental autoimmune myocarditis by blocking T cell activation through 4-1BB pathway
2009
Pitavastatin Suppresses Acute and Chronic Rejection in Murine Cardiac Allografts
2007
Inhibition of IκB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury
2004
Attenuation of Graft Arterial Disease by Manipulation of the LIGHT Pathway
2004
Pioglitazone Prevents Acute and Chronic Cardiac Allograft Rejection
2006
Blockade of the Interaction Between PD-1 and PD-L1 Accelerates Graft Arterial Disease in Cardiac Allografts
2004
Rankless by CCL
2026